Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Plos One|June 1, 2011
The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cellsChristiane A Opitz, Ulrike M Litzenburger, Uta Opitz, et al.
Life Science Alliance|June 19, 2021
Profiling chromatin accessibility responses in human neutrophils with sensitive pathogen detectionNikhil Ram-Mohan, Simone A Thair, Ulrike M Litzenburger, et al.
Genome Biology|January 26, 2017
Single-cell epigenomic variability reveals functional cancer heterogeneityUlrike M Litzenburger, Jason D Buenrostro, Beijing Wu, et al.
Nature|June 18, 2015
Single-cell chromatin accessibility reveals principles of regulatory variationJason D Buenrostro, Beijing Wu, Ulrike M Litzenburger, et al.
Nature Communications|November 4, 2018
Joint single-cell DNA accessibility and protein epitope profiling reveals environmental regulation of epigenomic heterogeneityXingqi Chen, Ulrike M Litzenburger, Yuning Wei, et al.
Plos One|October 19, 2012
Promotion of glioblastoma cell motility by enhancer of zeste homolog 2 (EZH2) is mediated by AXL receptor kinaseMartina Ott, Ulrike M Litzenburger, Felix Sahm, et al.
Glia|August 19, 2014
Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathwayMartina Ott, Ulrike M Litzenburger, Katharina J Rauschenbach, et al.
Oncotarget|March 25, 2014
Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHRUlrike M Litzenburger, Christiane A Opitz, Felix Sahm, et al.
Pageof 2